Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Fusion Pharmaceuticals Inc. - Common Shares
(NQ:
FUSN
)
21.55
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
21.55
Bid (Size)
21.65 (33)
Ask (Size)
21.87 (1)
Prev. Close
21.55
Today's Range
21.55 - 21.55
52wk Range
N/A - N/A
Shares Outstanding
63,846,009
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
May 09, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q1 2024
May 07, 2024
FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Performance
More News
Read More
Top 4 Health Care Stocks That May Plunge This Month
April 26, 2024
Via
Benzinga
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
Via
Investor's Business Daily
Recap: Fusion Pharmaceuticals Q4 Earnings
March 20, 2024
Via
Benzinga
Unveiling 11 Analyst Insights On Fusion Pharmaceuticals
March 20, 2024
Via
Benzinga
Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm
March 19, 2024
Via
News Direct
AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost
April 11, 2024
Via
Benzinga
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
April 02, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)
April 01, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)
March 25, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023
March 20, 2024
Via
InvestorPlace
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
March 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
March 19, 2024
Via
Benzinga
Topics
Stocks
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
March 19, 2024
Via
Benzinga
Topics
Stocks
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq –
March 19, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
Via
Benzinga
Topics
Stocks
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) Records 52-Week High Tuesday Morning
March 19, 2024
Via
Investor Brand Network
Nasdaq Down 100 Points; US Housing Starts Surge In February
March 19, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 19, 2024
Via
Benzinga
Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover
March 19, 2024
Via
Investor's Business Daily
Why Is Greenwave Tech Solutions (GWAV) Stock Down 53% Today?
March 19, 2024
Via
InvestorPlace
Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
March 19, 2024
Via
Benzinga
Frequently Asked Questions
Is Fusion Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, Fusion Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does Fusion Pharmaceuticals Inc. - Common Shares trade on?
Fusion Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Fusion Pharmaceuticals Inc. - Common Shares?
The ticker symbol for Fusion Pharmaceuticals Inc. - Common Shares is FUSN on the Nasdaq Stock Market
What is the current price of Fusion Pharmaceuticals Inc. - Common Shares?
The current price of Fusion Pharmaceuticals Inc. - Common Shares is 21.55
When was Fusion Pharmaceuticals Inc. - Common Shares last traded?
The last trade of Fusion Pharmaceuticals Inc. - Common Shares was at 06/03/24 04:00 PM ET
What is the market capitalization of Fusion Pharmaceuticals Inc. - Common Shares?
The market capitalization of Fusion Pharmaceuticals Inc. - Common Shares is 1.38B
How many shares of Fusion Pharmaceuticals Inc. - Common Shares are outstanding?
Fusion Pharmaceuticals Inc. - Common Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.